Moelis & Company
Independent investment bank advising on mergers, restructurings, capital markets, and private capital.
Something off on this page? Send us feedback.
Profile
Advises corporations, financial sponsors, governments, and sovereign wealth funds on mergers, restructurings, capital markets, and private-capital transactions, earning substantially all revenue from advisory fees. Operates one global advisory segment without balance-sheet lending or trading, leaving fees sensitive to deal completion and client activity.
Advises corporations, financial sponsors, governments, and sovereign wealth funds through M&A and Strategic Advisory, Capital Markets, Capital Structure Advisory, and Private Capital Advisory. Work spans mergers, divestitures, shareholder matters, public and private financings, restructurings, and private-fund primary and secondary transactions across the Americas, Europe, the Middle East, Asia, and Australia.
Operates as an independent, single-segment advisory firm rather than a lender or trading platform. Senior bankers combine industry, product, and regional expertise across engagements, while a discretionary compensation model supports collaboration across the global platform.
Earns substantially all revenue from advisory engagements, with many transaction fees contingent on completion. Results therefore depend on client activity, market and financing conditions, regulatory approvals, transaction timing, and retaining bankers with client relationships.
Company facts
Categories
Key statistics
Year to date −4.0% · Average volume (30d) 875.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Deutsche Bank | Reiterate | Buy | $80 | $75 | |
| Jul 30, 2026 | Morgan Stanley | Reiterate | Overweight | $83 | $85 | |
| Jul 8, 2026 | UBS | Downgrade | Neutral | Sell | ||
| Jul 7, 2026 | UBS | Downgrade | Neutral | Sell | $58 | $60 |
| Apr 9, 2026 | Morgan Stanley | Reiterate | Overweight | $92 | $83 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026Q2 FY26 | $0.62 | $0.63 | +2.1% | $387.3M | $409.4M | +5.7% | +4.75% |
| Apr 29, 2026Q1 FY26 | $0.59 | $0.50 | −15.3% | $321.5M | $319.8M | −0.5% | −2.88% |
| Feb 4, 2026Q4 FY25 | $0.76 | $1.13 | +48.7% | $441.2M | $487.9M | +10.6% | +1.11% |
| Oct 29, 2025Q3 FY25 | $0.57 | $0.68 | +19.3% | $430.2M | $356.9M | −17.0% | −3.85% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $306.6M | $365.4M | $356.9M | $487.9M | $319.8M | $409.4M | |
| Gross profit | $95.0M | $113.3M | $101.5M | $484.6M | $109.4M | $405.0M | |
| Operating income | $36.9M | $60.6M | $48.3M | $128.0M | $40.5M | $72.8M | |
| Net income | $50.3M | $41.5M | $53.4M | $87.9M | $38.4M | $48.6M | |
| Diluted EPS | $0.64 | $0.53 | $0.67 | $1.10 | $0.48 | $0.62 | |
| Gross margin | 31.0% | 31.0% | 28.4% | 99.3% | 34.2% | 98.9% | |
| Operating margin | 12.0% | 16.6% | 13.5% | 26.2% | 12.7% | 17.8% |
Fiscal years (4-quarter sums)FY21 $1.54B · FY22 $985.3M · FY23 $854.7M · FY24 $1.19B · FY25 $1.52B
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $207.7M · Total debt $262.8M · Total assets $1.41B · Shareholders' equity $505.8M
Dividends
Raised for 5 straight years — most recently to $0.65 from $0.60 in Feb 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 10, 2026 | Aug 10 | Sep 17 | $0.65 | |
| May 11, 2026 | May 11 | Jun 18 | $0.65 | |
| Feb 17, 2026 | Feb 17 | Mar 26 | $0.65 | |
| Nov 10, 2025 | Nov 10 | Dec 4 | $0.65 | |
| Aug 4, 2025 | Aug 4 | Sep 18 | $0.65 | |
| May 5, 2025 | May 5 | Jun 20 | $0.65 | |
| Feb 18, 2025 | Feb 18 | Mar 27 | $0.65 | raised from $0.60 |
| Nov 4, 2024 | Nov 4 | Dec 2 | $0.60 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 74.08M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 9.06M | 12.23% | 13F | Aug 7, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 5.41M | 7.31% | 13F | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 4.49M | 6.06% | 13F | Aug 13, 2026 |
| Kenneth Moelis · director, officer: Executive Chairman | 4.40M | 5.94% | Form 4 | Feb 20, 2026 |
| Vanguard Capital Management LLC | 3.35M | 4.52% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 4, 2026 | Osamu R. Watanabe | officer: General Counsel, Secretary | −4,850 | $69.30 |
| Feb 19, 2026 | Osamu R. Watanabe | officer: General Counsel, Secretary | −2,765 | $62.23 |
Peers
- Evercore
Independent advisory-bank peer across M&A, restructuring, and capital
- Houlihan Lokey
Direct overlap in M&A, restructuring, capital solutions, and valuations
- Lazard
Global advisory peer in M&A, restructuring, and capital solutions
- PJT Partners
Independent advisory peer in M&A, restructuring, and private capital
- Goldman Sachs
Large-bank overlap in M&A, restructuring and financing mandates
- Morgan Stanley
Large-bank rival in M&A, capital markets, and restructuring
- Perella Weinberg Partners
Independent advisory peer across M&A, restructuring, and capital markets
- Jefferies Financial Group
Full-service IB peer across advisory, underwriting, and capital markets
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Moelis & Company | $68.40 | +0.02% | $5.07B | 23.8 | 19.5 | 3.2 | +12.1% |
| Evercore | $293.00 | +1.00% | $11.22B | 16.4 | 15.1 | 2.4 | +19.2% |
| Houlihan Lokey | $133.02 | 0.00% | $9.30B | 22.4 | 17.5 | 3.7 | −15.6% |
| Lazard | $43.64 | −0.07% | $4.25B | 21.0 | 13.7 | 1.3 | −2.7% |
| PJT Partners | $182.80 | −0.05% | $4.67B | 30.7 | 21.8 | 2.5 | +19.5% |
| Goldman Sachs | $1,033.62 | +0.05% | $305.03B | 16.0 | 14.8 | 2.6 | +39.5% |
| Morgan Stanley | $214.50 | −0.13% | $338.75B | 17.5 | 16.3 | 2.7 | +36.8% |
| Perella Weinberg Partners | $16.98 | 0.00% | $1.67B | 56.5 | 13.4 | 2.4 | +0.8% |
| Jefferies Financial Group | $53.09 | 0.00% | $10.80B | 14.8 | 13.3 | 0.9 | −11.5% |
| Median | 19.3 | 15.0 | 2.4 | +10.0% |